vs

Side-by-side financial comparison of FIRST UNITED CORP (FUNC) and STANDARD BIOTOOLS INC. (LAB). Click either name above to swap in a different company.

FIRST UNITED CORP is the larger business by last-quarter revenue ($23.2M vs $19.6M, roughly 1.2× STANDARD BIOTOOLS INC.). FIRST UNITED CORP runs the higher net margin — 24.9% vs -177.4%, a 202.3% gap on every dollar of revenue. On growth, FIRST UNITED CORP posted the faster year-over-year revenue change (11.9% vs -11.5%). FIRST UNITED CORP produced more free cash flow last quarter ($15.4M vs $-23.1M). Over the past eight quarters, FIRST UNITED CORP's revenue compounded faster (11.5% CAGR vs -12.2%).

United Breweries Holdings Limited (UBHL), also called UB Group, is the Indian subsidiary of Heineken N.V.. It is headquartered in UB City, Bangalore, Karnataka. Its core business includes beverages and investments in various sectors. The company markets beer under the Kingfisher brand, and owns various other brands of alcoholic beverages. United Breweries is India's largest producer of beer.

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

FUNC vs LAB — Head-to-Head

Bigger by revenue
FUNC
FUNC
1.2× larger
FUNC
$23.2M
$19.6M
LAB
Growing faster (revenue YoY)
FUNC
FUNC
+23.3% gap
FUNC
11.9%
-11.5%
LAB
Higher net margin
FUNC
FUNC
202.3% more per $
FUNC
24.9%
-177.4%
LAB
More free cash flow
FUNC
FUNC
$38.5M more FCF
FUNC
$15.4M
$-23.1M
LAB
Faster 2-yr revenue CAGR
FUNC
FUNC
Annualised
FUNC
11.5%
-12.2%
LAB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
FUNC
FUNC
LAB
LAB
Revenue
$23.2M
$19.6M
Net Profit
$5.8M
$-34.7M
Gross Margin
48.5%
Operating Margin
32.9%
-168.5%
Net Margin
24.9%
-177.4%
Revenue YoY
11.9%
-11.5%
Net Profit YoY
-6.6%
-28.8%
EPS (diluted)
$0.89
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FUNC
FUNC
LAB
LAB
Q4 25
$23.2M
Q3 25
$22.7M
$19.6M
Q2 25
$21.8M
$21.8M
Q1 25
$20.9M
$40.8M
Q4 24
$20.8M
Q3 24
$20.3M
$22.1M
Q2 24
$20.1M
$22.5M
Q1 24
$18.7M
$45.5M
Net Profit
FUNC
FUNC
LAB
LAB
Q4 25
$5.8M
Q3 25
$6.9M
$-34.7M
Q2 25
$6.0M
$-33.5M
Q1 25
$5.8M
$-26.0M
Q4 24
$6.2M
Q3 24
$5.8M
$-26.9M
Q2 24
$4.9M
$-45.7M
Q1 24
$3.7M
$-32.2M
Gross Margin
FUNC
FUNC
LAB
LAB
Q4 25
Q3 25
48.5%
Q2 25
48.8%
Q1 25
48.4%
Q4 24
Q3 24
54.9%
Q2 24
46.1%
Q1 24
53.1%
Operating Margin
FUNC
FUNC
LAB
LAB
Q4 25
32.9%
Q3 25
40.6%
-168.5%
Q2 25
36.5%
-118.1%
Q1 25
36.8%
-80.8%
Q4 24
39.2%
Q3 24
38.0%
-120.9%
Q2 24
32.5%
-134.5%
Q1 24
26.0%
-132.2%
Net Margin
FUNC
FUNC
LAB
LAB
Q4 25
24.9%
Q3 25
30.6%
-177.4%
Q2 25
27.5%
-153.7%
Q1 25
27.7%
-63.8%
Q4 24
29.8%
Q3 24
28.5%
-122.0%
Q2 24
24.5%
-203.3%
Q1 24
19.8%
-70.6%
EPS (diluted)
FUNC
FUNC
LAB
LAB
Q4 25
$0.89
Q3 25
$1.07
$-0.09
Q2 25
$0.92
$-0.09
Q1 25
$0.89
$-0.07
Q4 24
$0.95
Q3 24
$0.89
$-0.07
Q2 24
$0.75
$-0.12
Q1 24
$0.56
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FUNC
FUNC
LAB
LAB
Cash + ST InvestmentsLiquidity on hand
$131.6M
$129.4M
Total DebtLower is stronger
$95.9M
Stockholders' EquityBook value
$203.6M
$399.7M
Total Assets
$2.1B
$539.6M
Debt / EquityLower = less leverage
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FUNC
FUNC
LAB
LAB
Q4 25
$131.6M
Q3 25
$95.2M
$129.4M
Q2 25
$79.1M
$158.6M
Q1 25
$84.4M
$150.9M
Q4 24
$78.3M
Q3 24
$62.4M
$210.6M
Q2 24
$45.1M
$269.8M
Q1 24
$86.9M
$287.1M
Total Debt
FUNC
FUNC
LAB
LAB
Q4 25
$95.9M
Q3 25
$95.9M
Q2 25
$120.9M
Q1 25
$120.9M
Q4 24
$120.9M
Q3 24
$120.9M
$55.2M
Q2 24
$70.9M
$55.1M
Q1 24
$70.9M
$55.0M
Stockholders' Equity
FUNC
FUNC
LAB
LAB
Q4 25
$203.6M
Q3 25
$199.1M
$399.7M
Q2 25
$191.1M
$424.5M
Q1 25
$183.7M
$454.6M
Q4 24
$179.3M
Q3 24
$174.0M
$489.3M
Q2 24
$164.2M
$510.3M
Q1 24
$165.5M
$577.3M
Total Assets
FUNC
FUNC
LAB
LAB
Q4 25
$2.1B
Q3 25
$2.0B
$539.6M
Q2 25
$2.0B
$557.0M
Q1 25
$2.0B
$579.6M
Q4 24
$2.0B
Q3 24
$1.9B
$681.5M
Q2 24
$1.9B
$708.7M
Q1 24
$1.9B
$777.7M
Debt / Equity
FUNC
FUNC
LAB
LAB
Q4 25
0.47×
Q3 25
0.48×
Q2 25
0.63×
Q1 25
0.66×
Q4 24
0.67×
Q3 24
0.70×
0.11×
Q2 24
0.43×
0.11×
Q1 24
0.43×
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FUNC
FUNC
LAB
LAB
Operating Cash FlowLast quarter
$19.4M
$-22.2M
Free Cash FlowOCF − Capex
$15.4M
$-23.1M
FCF MarginFCF / Revenue
66.3%
-118.1%
Capex IntensityCapex / Revenue
17.1%
4.5%
Cash ConversionOCF / Net Profit
3.35×
TTM Free Cash FlowTrailing 4 quarters
$22.7M
$-111.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FUNC
FUNC
LAB
LAB
Q4 25
$19.4M
Q3 25
$1.5M
$-22.2M
Q2 25
$995.0K
$-20.7M
Q1 25
$7.0M
$-30.3M
Q4 24
$22.3M
Q3 24
$2.3M
$-27.9M
Q2 24
$7.2M
$-39.0M
Q1 24
$3.6M
$-62.5M
Free Cash Flow
FUNC
FUNC
LAB
LAB
Q4 25
$15.4M
Q3 25
$168.0K
$-23.1M
Q2 25
$706.0K
$-22.6M
Q1 25
$6.4M
$-35.3M
Q4 24
$20.4M
Q3 24
$588.0K
$-30.1M
Q2 24
$7.0M
$-41.0M
Q1 24
$3.5M
$-63.3M
FCF Margin
FUNC
FUNC
LAB
LAB
Q4 25
66.3%
Q3 25
0.7%
-118.1%
Q2 25
3.2%
-103.6%
Q1 25
30.5%
-86.6%
Q4 24
98.1%
Q3 24
2.9%
-136.4%
Q2 24
35.1%
-182.2%
Q1 24
18.9%
-138.9%
Capex Intensity
FUNC
FUNC
LAB
LAB
Q4 25
17.1%
Q3 25
5.9%
4.5%
Q2 25
1.3%
8.7%
Q1 25
2.8%
12.4%
Q4 24
9.3%
Q3 24
8.4%
10.2%
Q2 24
0.6%
8.6%
Q1 24
0.3%
1.7%
Cash Conversion
FUNC
FUNC
LAB
LAB
Q4 25
3.35×
Q3 25
0.22×
Q2 25
0.17×
Q1 25
1.20×
Q4 24
3.60×
Q3 24
0.40×
Q2 24
1.46×
Q1 24
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FUNC
FUNC

Trust Department$9.8M42%
Other$5.6M24%
Debit Card Income$4.1M17%
Service Charges$2.3M10%
Brokerage Commissions$1.4M6%

LAB
LAB

Consumables$8.7M45%
Services And Other Revenue$5.8M29%
Instruments$5.1M26%

Related Comparisons